Filter
132
Text search:
test
de
ELISA
Featured
Recommendations
23
New Publications
33
Language
Document type
No document type
68
Studies & Reports
25
Guidelines
23
Manuals
8
Fact sheets
5
Training Material
1
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
Senegal
6
Paraguay
6
Congo, Democratic Republic of
5
Latin America and the Carribbean
5
Sierra Leone
4
Liberia
4
Nigeria
4
Burkina Faso
3
India
3
Tanzania
3
Rwanda
3
Malawi
3
Brazil
3
Haiti
2
Philippines
2
Kenya
2
South Africa
2
Colombia
2
Ecuador
2
Bolivia
2
Lesotho
2
Africa
2
Eastern Europe
2
Global
2
Guinea
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Ethiopia
1
Ghana
1
Uganda
1
Togo
1
Zimbabwe
1
Nepal
1
Zambia
1
Chad
1
Eswatini/ Swaziland
1
East and Southern Africa
1
West and Central Africa
1
Western and Central Europe
1
Venezuela
1
Estonia
1
Authors & Publishers
Publication Years
Category
Countries
50
Clinical Guidelines
20
Pharmacy & Technologies
7
Public Health
4
Key Resources
3
Capacity Building
2
Women & Child Health
1
Toolboxes
NTDs
20
HIV
15
COVID-19
14
Ebola & Marburg
11
TB
8
Rapid Response
7
2.0 Rapid Response
4
Zika
3
Mental Health
3
Refugee
2
Caregiver
2
Planetary Health
2
Pharmacy
2
Cholera
1
Conflict
1
Natural Hazards
1
Global Health Education
1
Interim Recommendation published 19 September 2014. These recommendations reflect current understanding of Ebola virus disease (EVD) and are intended for national laboratory staff performing diagnostic testing to detect Ebola virus.
Technical report
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology ...
This manual aims to provide information about the methods for investigating outbreaks of hepatitis E, and measures for their prevention and control. In addition, the manual gives information about the causative agent – known as the hepatitis E virus (HEV) – its epidemiology ...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
The WHO Health Emergencies Programme is currently monitoring 118 events in the region. This week’s main articles cover the following events:
Coronavirus disease 2019 (COVID-19) in Togo
Measles in Chad
Ebola virus disease (EVD) in Équateur Province, Democratic Republic of the Congo.
...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
Second Edition
AIDS Medicines and diagnostics services
July 2015
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
